Literature DB >> 30559235

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2018 by the American Diabetes Association.

Entities:  

Year:  2019        PMID: 30559235     DOI: 10.2337/dc19-S009

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  263 in total

Review 1.  Current management of non-alcoholic steatohepatitis.

Authors:  Mark D Muthiah; Arun J Sanyal
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

2.  Perspective: Network Meta-analysis Reaches Nutrition Research: Current Status, Scientific Concepts, and Future Directions.

Authors:  Lukas Schwingshackl; Guido Schwarzer; Gerta Rücker; Joerg J Meerpohl
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

3.  The FDA Metformin Label Change and Racial and Sex Disparities in Metformin Prescription among Patients with CKD.

Authors:  Jung-Im Shin; Yingying Sang; Alex R Chang; Stephan C Dunning; Josef Coresh; Lesley A Inker; Elizabeth Selvin; Shoshana H Ballew; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

Review 4.  Designing a bioelectronic treatment for Type 1 diabetes: targeted parasympathetic modulation of insulin secretion.

Authors:  Elliott W Dirr; Morgan E Urdaneta; Yogi Patel; Richard D Johnson; Martha Campbell-Thompson; Kevin J Otto
Journal:  Bioelectron Med (Lond)       Date:  2020-07-28

Review 5.  Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes.

Authors:  Taichi Nagahisa; Yoshifumi Saisho
Journal:  Diabetes Ther       Date:  2019-08-22       Impact factor: 2.945

Review 6.  Glucose metabolism in Cushing's syndrome.

Authors:  Anu Sharma; Adrian Vella
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-06       Impact factor: 3.243

7.  Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney Disease.

Authors:  David Z Cherney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-04       Impact factor: 8.237

8.  Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults.

Authors:  Tiansheng Wang; Jeff Y Yang; John B Buse; Virginia Pate; Huilin Tang; Edward L Barnes; Robert S Sandler; Til Stürmer
Journal:  Diabetes Care       Date:  2019-08-30       Impact factor: 19.112

Review 9.  Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Authors:  Javed Butler; Milton Packer; Stephen J Greene; Mona Fiuzat; Stefan D Anker; Kevin J Anstrom; Peter E Carson; Lauren B Cooper; Gregg C Fonarow; Adrian F Hernandez; James L Januzzi; Mariell Jessup; Rita R Kalyani; Sanjay Kaul; Mikhail Kosiborod; JoAnn Lindenfeld; Darren K McGuire; Marc S Sabatine; Scott D Solomon; John R Teerlink; Muthiah Vaduganathan; Clyde W Yancy; Norman Stockbridge; Christopher M O'Connor
Journal:  Circulation       Date:  2019-12-16       Impact factor: 29.690

10.  Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005-2007 and 2015-2017.

Authors:  Xilin Zhou; Sundar S Shrestha; Hui Shao; Ping Zhang
Journal:  Diabetes Care       Date:  2020-07-31       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.